Jamison Private Wealth Management Inc. Has $334,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Jamison Private Wealth Management Inc. boosted its position in Colgate-Palmolive (NYSE:CL) by 531.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 3,670 shares of the company’s stock after purchasing an additional 3,089 shares during the quarter. Jamison Private Wealth Management Inc.’s holdings in Colgate-Palmolive were worth $334,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of CL. Toth Financial Advisory Corp grew its stake in Colgate-Palmolive by 1.6% in the fourth quarter. Toth Financial Advisory Corp now owns 55,878 shares of the company’s stock valued at $5,080,000 after purchasing an additional 883 shares in the last quarter. CFS Investment Advisory Services LLC grew its stake in Colgate-Palmolive by 10.1% in the fourth quarter. CFS Investment Advisory Services LLC now owns 13,114 shares of the company’s stock valued at $1,192,000 after purchasing an additional 1,203 shares in the last quarter. Grimes & Company Inc. grew its stake in Colgate-Palmolive by 3.4% in the fourth quarter. Grimes & Company Inc. now owns 12,503 shares of the company’s stock valued at $1,137,000 after purchasing an additional 410 shares in the last quarter. Lantz Financial LLC grew its stake in Colgate-Palmolive by 0.6% in the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after purchasing an additional 122 shares in the last quarter. Finally, DGS Capital Management LLC grew its stake in Colgate-Palmolive by 4.4% in the fourth quarter. DGS Capital Management LLC now owns 9,001 shares of the company’s stock valued at $818,000 after purchasing an additional 376 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $87.88 on Monday. The stock has a market capitalization of $71.79 billion, a PE ratio of 25.18, a P/E/G ratio of 3.59 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business has a fifty day moving average price of $91.81 and a two-hundred day moving average price of $97.45. Colgate-Palmolive has a fifty-two week low of $80.03 and a fifty-two week high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on CL shares. Wells Fargo & Company reduced their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Piper Sandler reduced their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Stifel Nicolaus reduced their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday, January 17th. Finally, Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.